Growth hormone fusion proteins
    6.
    发明授权
    Growth hormone fusion proteins 失效
    生长激素融合蛋白

    公开(公告)号:US08470559B2

    公开(公告)日:2013-06-25

    申请号:US13620004

    申请日:2012-09-14

    摘要: We disclose growth hormone [GH] fusion proteins that have increased in vivo stability and activity; nucleic acid molecules encoding said proteins and methods of treatment of growth hormone deficiency that use said fusion proteins. The GH fusion proteins comprise human GH covalently linked to the extracellular domain of Growth Hormone Receptor [GHR] either as a direct in-frame translational fusion or via a flexible peptide linker. The GH/GHR fusion proteins have exceptional pharmacokinetics and are potent growth hormone receptor agonists. The GH/GHR fusion proteins form head to tail dimers.

    摘要翻译: 我们公开了增加体内稳定性和活性的生长激素[GH]融合蛋白; 编码所述蛋白质的核酸分子和使用所述融合蛋白的生长激素缺乏症的治疗方法。 GH融合蛋白包括与生长激素受体[GHR]的细胞外结构域共价连接的人GH,作为直接的帧内翻译融合或通过柔性肽接头。 GH / GHR融合蛋白具有特殊的药代动力学,是有效的生长激素受体激动剂。 GH / GHR融合蛋白形成头对尾二聚体。

    Polypeptide variants
    10.
    发明申请
    Polypeptide variants 审中-公开
    多肽变体

    公开(公告)号:US20070054364A1

    公开(公告)日:2007-03-08

    申请号:US11595991

    申请日:2006-11-13

    摘要: The invention relates to the provision of oligomeric polypeptides (dimers, trimers etc) comprising the ligand binding domains of cytokines which are linked via flexible polypeptide linker molecules. The linker molecules optionally comprise protease sensitive sites to modulate the release of biologically active cytokines when administered to a human or animal subject.

    摘要翻译: 本发明涉及提供包含通过柔性多肽接头分子连接的细胞因子的配体结合结构域的寡聚多肽(二聚体,三聚体等)。 连接分子任选地包含蛋白酶敏感位点,以在施用于人或动物受试者时调节生物活性细胞因子的释放。